A Study of Psilocybin for Major Depressive Disorder (MDD)

Clinical trial NCT03866174 · COMPLETED

Trial details

NCT number: NCT03866174
Sponsor: Usona Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Depressive Disorder, Major

Start date: 2020-01-23
Primary completion: 2022-06-28
Enrollment: 347

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.